Skip to content
Screener

Ocular Therapeutix OCUL Business Segments — Investment Income Net

Similar metrics at other companies

AMC Robotics Corporation logo
AMCIReportable Segment Aggregation Before Other Operating — Investment Income Net
$28.65K+8,910%
Constellation Brands logo
STZConstellationwinesandspirits — Investment Income Net
$23.5M+257%
CPH
CPHCDevelopment — Investment Income Net
$375K+26.7%
UFP Industries, Inc. logo
UFPIConstruction — Investment Income Net
$12K
UFP Industries, Inc. logo
UFPIRetail — Investment Income Net
$87K+3.6%
St. Joe Company logo
JOECommercial — Investment Income Net
$4K-66.7%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$1.92B-11.7%
Enterprise value$1.33B-28.4%
P/S36.9×-1.5×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-055256
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
General and administrative (a)11,6069,661
Facilities (b)2,2701,664
Stock-based compensation15,58210,456
Depreciation1,260981
Interest income6,0503,826
Interest expense(2,777)(2,984)
Other non-operating items1,455(978)
Net loss$(88,612)$(64,053)

Item 1. Financial Statements (unaudited)

FAQ

What is Ocular Therapeutix's business segments — investment income net?
Ocular Therapeutix (OCUL) reported business segments — investment income net of $6.05M in Q1 2026.
How has Ocular Therapeutix's business segments — investment income net changed year-over-year?
Ocular Therapeutix's business segments — investment income net increased by 58.1% year-over-year, from $3.83M to $6.05M.
What is the long-term trend for Ocular Therapeutix's business segments — investment income net?
Over 3 years (2022 to 2025), Ocular Therapeutix's business segments — investment income net has grown at a 37.7% compound annual growth rate (CAGR), from -$7.02M to $18.35M.
What does business segments — investment income net mean?
This represents the net earnings generated from the company's cash, cash equivalents, and marketable securities held within its primary business operations. It reflects the yield on the company's treasury management and liquidity position. A positive trend indicates effective utilization of excess capital to generate supplemental returns.

Ask your AI about Ocular Therapeutix's business segments — investment income net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude